These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33587443)

  • 1. A randomized, placebo-controlled, double-blinded clinical trial of colchicine to improve vascular health in people living with HIV.
    Hays AG; Schär M; Barditch-Crovo P; Bagchi S; Bonanno G; Meyer J; Afework Y; Streeb V; Stradley S; Kelly S; Anders NM; Margolick JB; Lai S; Gerstenblith G; Weiss RG
    AIDS; 2021 Jun; 35(7):1041-1050. PubMed ID: 33587443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship Between Impaired Coronary Endothelial Function and Systemic Markers of Inflammation in People Living With HIV.
    Bagchi S; Kwapong YA; Schär M; Bonanno G; Streeb V; Lai S; Gerstenblith G; Weiss RG; Hays AG
    J Acquir Immune Defic Syndr; 2023 May; 93(1):47-54. PubMed ID: 36634369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Trial of Anti-inflammatory Medications and Coronary Endothelial Dysfunction in Patients With Stable Coronary Disease.
    Hays AG; Schär M; Bonanno G; Lai S; Meyer J; Afework Y; Steinberg A; Stradley S; Gerstenblith G; Weiss RG
    Front Cardiovasc Med; 2021; 8():728654. PubMed ID: 34722661
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronary artery endothelial function and aging in people with HIV and HIV-negative individuals.
    Ziogos E; Kwapong YA; Weiss RG; Schär M; Brown TT; Bagchi S; Soleimanifard A; Harb T; Piggott DA; Gerstenblith G; Leucker TM; Hays AG
    Am J Physiol Heart Circ Physiol; 2023 Nov; 325(5):H1099-H1107. PubMed ID: 37682238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of febuxostat on coronary artery endothelial dysfunction in patients with coronary artery disease: A phase 4 randomized, placebo-controlled, double-blind, crossover trial.
    Hays AG; Iantorno M; Schär M; Lai S; Czarny M; Breton E; Palmer RN; Whelton A; Weiss RG; Gerstenblith G
    Am Heart J; 2018 Mar; 197():85-93. PubMed ID: 29447788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional coronary endothelial dysfunction is related to the degree of local epicardial fat in people with HIV.
    Iantorno M; Soleimanifard S; Schär M; Brown TT; Bonanno G; Barditch-Crovo P; Mathews L; Lai S; Gerstenblith G; Weiss RG; Hays AG
    Atherosclerosis; 2018 Nov; 278():7-14. PubMed ID: 30227267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of short-term colchicine treatment on endothelial function in patients with coronary artery disease.
    Kajikawa M; Higashi Y; Tomiyama H; Maruhashi T; Kurisu S; Kihara Y; Mutoh A; Ueda SI
    Int J Cardiol; 2019 Apr; 281():35-39. PubMed ID: 30683457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery endothelial dysfunction is present in HIV-positive individuals without significant coronary artery disease.
    Iantorno M; Schär M; Soleimanifard S; Brown TT; Moore R; Barditch-Crovo P; Stuber M; Lai S; Gerstenblith G; Weiss RG; Hays AG
    AIDS; 2017 Jun; 31(9):1281-1289. PubMed ID: 28353539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics.
    Nidorf SM; Fiolet ATL; Eikelboom JW; Schut A; Opstal TSJ; Bax WA; Budgeon CA; Tijssen JGP; Mosterd A; Cornel JH; Thompson PL;
    Am Heart J; 2019 Dec; 218():46-56. PubMed ID: 31706144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Sex on Coronary Endothelial Dysfunction in People Living With HIV.
    Minhas AS; Leucker TM; Goerlich E; Soleimani-Fard A; Schär M; Ziogos E; Miller E; Gerstenblith G; Hays AG
    J Am Heart Assoc; 2022 Dec; 11(23):e026428. PubMed ID: 36382948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary Endothelial Dysfunction in People Living With HIV Is Related to Body Fat Distribution.
    Goerlich E; Schär M; Bagchi S; Soleimani-Fard A; Brown TT; Sarkar S; Bonanno G; Streeb V; Gerstenblith G; Barditch-Crovo P; Weiss RG; Hays AG
    J Acquir Immune Defic Syndr; 2022 Jun; 90(2):201-207. PubMed ID: 35131972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colchicine in ischemic heart disease: the good, the bad and the ugly.
    D'Amario D; Cappetta D; Cappannoli L; Princi G; Migliaro S; Diana G; Chouchane K; Borovac JA; Restivo A; Arcudi A; De Angelis A; Vergallo R; Montone RA; Galli M; Liuzzo G; Crea F
    Clin Res Cardiol; 2021 Oct; 110(10):1531-1542. PubMed ID: 33713178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial.
    Akrami M; Izadpanah P; Bazrafshan M; Hatamipour U; Nouraein N; Drissi HB; Manafi A
    BMC Cardiovasc Disord; 2021 Dec; 21(1):583. PubMed ID: 34876021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colchicine may become a new cornerstone therapy for coronary artery disease: a meta-analysis of randomized controlled trials.
    Chen Y; Zhang H; Chen Y; Li M; Luo W; Liu Y; Fu Y; Xia H; Xu C; Jiang Y; Wu Y
    Clin Rheumatol; 2022 Jun; 41(6):1873-1887. PubMed ID: 35138464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary vasomotor responses to isometric handgrip exercise are primarily mediated by nitric oxide: a noninvasive MRI test of coronary endothelial function.
    Hays AG; Iantorno M; Soleimanifard S; Steinberg A; Schär M; Gerstenblith G; Stuber M; Weiss RG
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(11):H1343-50. PubMed ID: 25820391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolocumab, a PCSK9-Monoclonal Antibody, Rapidly Reverses Coronary Artery Endothelial Dysfunction in People Living With HIV and People With Dyslipidemia.
    Leucker TM; Gerstenblith G; Schär M; Brown TT; Jones SR; Afework Y; Weiss RG; Hays AG
    J Am Heart Assoc; 2020 Jul; 9(14):e016263. PubMed ID: 32674634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention.
    Hoffmann U; Lu MT; Foldyna B; Zanni MV; Karady J; Taron J; Zhai BK; Burdo T; Fitch KV; Kileel EM; Williams K; Fichtenbaum CJ; Overton ET; Malvestutto C; Aberg J; Currier J; Sponseller CA; Melbourne K; Floris-Moore M; Van Dam C; Keefer MC; Koletar SL; Douglas PS; Ribaudo H; Mayrhofer T; Grinspoon SK;
    JAMA Netw Open; 2021 Jun; 4(6):e2114923. PubMed ID: 34185068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colchicine for acute gout.
    McKenzie BJ; Wechalekar MD; Johnston RV; Schlesinger N; Buchbinder R
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD006190. PubMed ID: 34438469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colchicine for the Prevention of Cardiovascular Disease: Potential Global Implementation.
    Zhang RS; Weber BN; Araiza-Garaygordobil D; Garshick MS
    Curr Cardiol Rep; 2024 May; 26(5):423-434. PubMed ID: 38573553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colchicine for acute gout.
    van Echteld I; Wechalekar MD; Schlesinger N; Buchbinder R; Aletaha D
    Cochrane Database Syst Rev; 2014 Aug; (8):CD006190. PubMed ID: 25123076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.